Register / Log In

DEA recognizes LTC nurses as agents of prescribers


The Drug Enforcement Agency (DEA) has changed its policy and now recognizes long-term-care (LTC) nurses as agents of prescribers of Schedule C-III through C-V medications, according to a Federal Register notice released today.

In the Federal Register notice, a DEA policy statement outlines the proper roles of agents — including but not limited to LTC nurses — and a practitioner when there is no employer-employee relationship. In addition, the notice provides guidance about the differences between prescription requirements for Schedule II and Schedule III through V medications, defines what constitutes an agent, summarizes the requirements of a prescription, and covers the rules associated with faxing prescriptions for controlled substances.

The American Society of Consultant Pharmacists (ASCP) has advocated for many years to change DEA policies for patients in LTC facilities who encountered delays in access to prescribed medications that were subject to regulation under the Controlled Substances Act. “We commend the DEA for clearing the way for improved quality care for patients,” said ASCP President-Elect Albert Barber, PharmD, CGP, FASCP, in a press release.

“By allowing the long-term-care nurse to serve as an agent of the prescribing physician, orders for C-III through C-V controlled medications can be communicated to the pharmacy in a more efficient and timely manner. Patients will now be at a much lower risk of encountering delays for medications to alleviate their pain,” Barber continued.

In the July issue of Drug Topics (Regulatory & Legal, “1995 DEA letter surfaces”), Ned Milenkovich, PharmD, JD, pointed out that the DEA had previously allowed LTC nurses to give verbal orders, according to a 1995 letter addressed to the Missouri Department of Health. However, in a Federal Register notice in April 2001, DEA would “not recognize an ‘agency’ relationship between a prescribing practitioner and an LTC nurse.”

Today’s announcement reverses the 2001 DEA decision. The Federal Register notice of October 6, 2010, can be accessed at controlled substances and authorized agents.

Recalling the desperate fight for life that was waged by juvenile diabetes patients not even a century ago, "Breakthrough: The Dramatic Story of the Discovery of Insulin" will be on view at the New York Historical Society from October 2010 through January 2011.

This article reviews key concepts dealing with influenza, describes the process of antigenic drift and shift, summarizes current data surrounding the 2009 H1N1 pandemic, and discusses recommendations for prevention and treatment of the disease.

Erectile dysfunction (ED) drugs purchased online may be worse than useless. They could pose significant health risks.

A survey of new Rx, new generic, and new OTC products

Each year, community pharmacists are recognized by their peers through nominations for Drug Topics' annual Top Independent Pharmacists awards, which honor 3 pharmacists or pharmacy teams for their contributions to local life.